STOCKHOLDERS DEFICIENCY (Details 2)	6 Months Ended
	Dec. 31, 2024 USD ($) $ / shares shares
STOCKHOLDERS DEFICIENCY
Number of Options Outstanding, Beginning | shares	2,263,440
Number of Options Expired | shares	(14,338)
Number of Options Outstanding, Ending | shares	2,249,102
Number of Options Exercisable | shares	935,714
Number of Options Expected to vest | shares	1,313,387
Weighted Average Exercise Price Outstanding, Beginning | $ / shares	$ 6.11
Weighted Average Exercise Price Expired | $ / shares	4.50
Weighted Average Exercise Price Outstanding, Ending | $ / shares	6.12
Weighted Average Exercise Price Exercisable | $ / shares	10.76
Weighted Average Exercise Price Options Expected to vest | $ / shares	$ 2.82
Weighted Average Remaining Term in Years Options outstanding at beginning of year	8 years 2 months 12 days
Weighted Average Remaining Term in Years Options outstanding at end of year	7 years 8 months 12 days
Weighted Average Remaining Term in Years Options exercisable at end of year	6 years 1 month 6 days
Weighted Average Remaining Term in Years Options Expected to vest	8 years 10 months 24 days
Aggregate Intrinsic Value Options Expected to vest | $	$ 0
Aggregate Intrinsic Value Options Expected to outstanding | $	0
Aggregate Intrinsic Value Options Exercisable | $	$ 0